Invention Grant
- Patent Title: Complement pathway modulators and uses thereof
- Patent Title (中): 补体途径调节剂及其用途
-
Application No.: US13342161Application Date: 2012-01-02
-
Publication No.: US09085555B2Publication Date: 2015-07-21
- Inventor: Eva Altmann , Ulrich Hommel , Edwige Liliane Jeanne Lorthiois , Juergen Klaus Maibaum , Nils Ostermann , Jean Quancard , Stefan Andreas Randl , Olivier Rogel , Oliver Simic , Anna Vulpetti
- Applicant: Eva Altmann , Ulrich Hommel , Edwige Liliane Jeanne Lorthiois , Juergen Klaus Maibaum , Nils Ostermann , Jean Quancard , Stefan Andreas Randl , Oliver Simic , Anna Vulpetti , Véronique Stark-Rogel
- Applicant Address: CH Basel
- Assignee: NOVARTIS AG
- Current Assignee: NOVARTIS AG
- Current Assignee Address: CH Basel
- Agent John B. Alexander
- Main IPC: C07D471/04
- IPC: C07D471/04 ; C07D487/04 ; A61K31/437 ; A61K31/404 ; C07D403/12 ; C07D401/14 ; C07D403/14 ; C07D405/14 ; C07D409/14 ; C07D417/12 ; C07D417/14
Abstract:
The present invention provides a compound of formula I: a method for manufacturing the compounds of the invention, and its therapeutic uses. The present invention further provides a combination of pharmacologically active agents and a pharmaceutical composition.
Public/Granted literature
- US20120295884A1 Complement pathway modulators and uses thereof Public/Granted day:2012-11-22
Information query
